1. Home
  2. CRVS vs WINA Comparison

CRVS vs WINA Comparison

Compare CRVS & WINA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$14.03

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Winmark Corporation

WINA

Winmark Corporation

HOLD

Current Price

$353.47

Market Cap

1.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRVS
WINA
Founded
2014
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
2016
2006

Fundamental Metrics

Financial Performance
Metric
CRVS
WINA
Price
$14.03
$353.47
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$30.17
N/A
AVG Volume (30 Days)
1.0M
36.8K
Earning Date
05-07-2026
04-15-2026
Dividend Yield
N/A
3.76%
EPS Growth
48.04
3.76
EPS
N/A
5.31
Revenue
N/A
$86,055,700.00
Revenue This Year
N/A
$5.55
Revenue Next Year
N/A
$6.03
P/E Ratio
N/A
$65.71
Revenue Growth
N/A
5.86
52 Week Low
$4.05
$325.06
52 Week High
$26.95
$526.81

Technical Indicators

Market Signals
Indicator
CRVS
WINA
Relative Strength Index (RSI) 50.71 N/A
Support Level $12.74 N/A
Resistance Level $14.00 N/A
Average True Range (ATR) 0.69 0.00
MACD -0.12 0.00
Stochastic Oscillator 49.44 0.00

Price Performance

Historical Comparison
CRVS
WINA

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

About WINA Winmark Corporation

Winmark Corp is a franchisor of value-oriented retail store concepts that buy, sell, and trade gently used merchandise. The company has one reportable segment, including Franchising, and one non-reportable segment, Leasing. The franchising segment franchises value-oriented retail stores that buy, sell, trade, and consign merchandise as well as provide strategic consulting services relating to franchising. The leasing segment includes the middle-market equipment leasing business and small-ticket financing business. It generates a majority of its revenue from the Franchising segment.

Share on Social Networks: